Metastatic Colon Cancer Completed Phase 2 Trials for Cetuximab (DB00002)

Also known as: Colon cancer metastatic / Stage IV Colon Cancer / Colon cancer stage IV / Malignant neoplasm of colon stage IV / Colon cancer Duke's D / Malignant neoplasm of colon stage IV, unspecified

IndicationStatusPhase
DBCOND0033231 (Metastatic Colon Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01292356Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor ResponseTreatment
NCT00100841Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal CancerTreatment